EMA — authorised 14 January 2019
- Marketing authorisation holder: JANSSEN-CILAG INTERNATIONAL N.V.
- Status: approved
🇪🇺 Erleada in European Union
EMA authorised Erleada on 14 January 2019
Marketing authorisation
Erleada in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Erleada approved in European Union?
Yes. EMA authorised it on 14 January 2019.
Who is the marketing authorisation holder for Erleada in European Union?
JANSSEN-CILAG INTERNATIONAL N.V. holds the EU marketing authorisation.